Essential Updates in Nephrology CME
The Cleveland Clinic Nephrology Update 2025 — This year’s update will provide a review of the most up-to-date data and analyze it for implications in clinical practice, as well as focus on the most recent current topics that impact your practice. Cleveland Clinic Nephrology Update 2025 features experts that will address diagnosis and management strategies for patients with kidney disease.
* Date of Original Release: April 23-25, 2025
LEARNING OBJECTIVES
Upon completion of this activity, the participant will be able to:
- Describe and critically appraise recent advancements in chronic kidney disease management, including the integration of novel pharmacotherapies such as SGLT2 inhibitors, GLP-receptor agonists, and non-steroidal MRAs into treatment plans.
- Discuss the management of various complications in CKD and ESKD.
- Discuss obesity in CKD and the role of nephrology providers.
- Evaluate the latest evidence-based treatment strategies for IgA nephropathy and lupus nephritis, with a focus on novel therapies.
- Analyze the role of complement activation in various kidney diseases and explore the role of novel therapeutic interventions targeting the complement system.
- Highlight updated approaches to managing kidney-related complications in cancer patients, including the nephrotoxic effects of immune checkpoint inhibitors and targeted cancer therapeutics.
- Review the basics of dialysis vascular access and critically appraise recent advances in the field.
- Assess the unique challenges of managing kidney disease in pregnant patients, including hypertension, preeclampsia, and acute kidney injury, with a focus on balancing maternal and fetal health.
CLEVELAND CLINIC NEPHROLOGY UPDATE 2025
